Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

107.13 +1.86 (+1.77%)
Streaming Delayed Price Updated: 1:55 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Abbott Stock: Bear vs. Bull
Abbott is a favorite of income-oriented investors, but is the price right? 
Via The Motley Fool
P/E Ratio Insights for Abbott Laboratories
Via Benzinga
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
Tech stocks were the primary fuel for a decades-long bull market, and these three Nasdaq stocks to buy can lead the market forward. 
Via InvestorPlace
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
This Is What Whales Are Betting On Abbott Laboratories
Via Benzinga
(ABT) - Analyzing Abbott Laboratories's Short Interest
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
Via Benzinga
Is Abbott Laboratories a Buy?
If you're willing to invest with the right mindset, it could be a great option. 
Via The Motley Fool
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood... 
Via Benzinga
2 Dividend Kings to Buy on the Dip and Hold Forever
Don't ignore these stocks just because the rest of the market is. 
Via The Motley Fool
Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money. 
Via Benzinga
Could Abbott Laboratories Stock Help You Become a Millionaire?
One promising area of its business is diabetes care, which experienced significant growth this year. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Looking At Abbott Laboratories's Recent Unusual Options Activity
Via Benzinga
2 Incredible Stocks to Buy on the Dip
Today's bargain may pay off big down the road. 
Via The Motley Fool
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
You'll want to hold on to these players for the long term. 
Via The Motley Fool
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term. 
Via InvestorPlace
The 3 Best Pharma Stocks to Buy Now: September 2023
There are pharma stocks to buy for each type of investor. This article explores the best options in the industry. 
Via InvestorPlace
Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?
Its latest pullback could be an opportunity to buy a legendary dividend stock before it begins a long upward climb. 
Via The Motley Fool
The 3 Most Promising Healthcare Stocks to Own Now
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products. 
Via InvestorPlace
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
Via Benzinga
This Is What Whales Are Betting On Abbott Laboratories
Via Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These reliable dividend payers are a fantastic opportunity for investors to generate passive income. 
Via The Motley Fool
How Lawmakers Want To Stop Cronobacter Outbreaks That Spurred Baby Formula Shortage Last Year
Under bipartisan Congressional legislation, baby formula manufacturers must notify the U.S. 
Via Benzinga
1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling
Some of the world's most successful investors are focusing on stocks. 
Via The Motley Fool
U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio
Looking for stocks to buy amid the U.S. credit rating downgrade? Look no further. These companies have you covered. 
Via InvestorPlace
Want Growing Passive Income? This Dividend King Could Be a Smart Buy
The company boasts one of the longest dividend growth streaks in the healthcare sector. 
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Investors can expect steady returns from these two longtime market-beaters. 
Via The Motley Fool
Down 4% to 17%, These Monster Dividend Stocks Could Be Picking Up Steam
These companies have shown they can increase their lucrative dividends regardless of company struggles in recent times. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.